Evidence map›Paper›PMID 32188442›Full record

Trial reportMalaria journal2020

Genetic diversity of Plasmodium falciparum and genetic profile in children affected by uncomplicated malaria in Cameroon.

Theresia Njuabe Metoh, Jun-Hu Chen, Philip Fon-Gah, Xia Zhou, Roger Moyou-Somo, Xiao-Nong Zhou

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Malaria journal, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02974348 (Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa), which is not on this map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
7.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02974348 phase3completednot on this map

Assessment of Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa

TypeinterventionalSponsorUniversity of BamendaRan2013 to 2014Enrolled300ConditionsDrug Resistant Malaria Due to Plasmodium FalciparumArmsArthemeter-lumefantrine, Artesunate mefloquine, Dihydroartemisinin piperaquine, Paracetamol, Amoxicillin
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Parasite epidemiology and control · 2026
    Article
  5. Genetic metrics decodeFrontiers in genetics · 2026
    Article
  6. Genetic Diversity ofThe Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2026
    Article
  7. Article
  8. Article
  9. Review
  10. Genetic Diversity ofTropical medicine and infectious disease · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Genotyping and CharacterizingTropical medicine and infectious disease · 2024
    Review
  16. Article
  17. Parasite epidemiology and control · 2024
    Article
  18. Exploring the relationship betweenThe Pan African medical journal · 2024
    Article
  19. Article
  20. High Prevalence of PolyclonalTropical medicine and infectious disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Theresia Njuabe MetohDepartment of Biochemistry, Faculty of Science, The University of Bamenda, P. O. Box 39 Bambili, Bamenda, Cameroon. njuabe@yahoo.fr.ORCID http://orcid.org/0000-0003-3010-4380
Jun-Hu ChenNational Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention, Shanghai, 200025, People's Republic of China.
Philip Fon-GahITC Enschede, University of Twenty, Hengelosestraat 99, 7514 AE, Enschede, The Netherlands.
Xia ZhouNational Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention, Shanghai, 200025, People's Republic of China.
Roger Moyou-SomoInstitute of Medical Research and Medicinal Plants-IMPM, P. O. 6123, Yaoundé, Cameroon.
Xiao-Nong ZhouNational Institute of Parasitic Diseases, Chinese Centre for Disease Control and Prevention, Shanghai, 200025, People's Republic of China.
National Institute for Parasitic Diseases · CNUniversité de Yaoundé I · CMUniversity of Bamenda · CM

Funding

CASTEP China-Africa science and technology programChina UK Global Health Support Programme GHSP-CS-OP1from the Chinese National Science and Technology 2012ZX10004-220International Collaboration Project from the Ministry of Science and Technology 2010DF33970
6 · The paper itself

Abstract

backgroundMalaria is a major public health problem in Cameroon. The study of the genetic diversity within parasite population is essential for understanding the mechanism underlying malaria pathology and to determine parasite clones profile in an infection, for proper malaria control strategies. The objective of this study was to perform a molecular characterization of highly polymorphic genetic markers of Plasmodium falciparum, and to determine allelic distribution with their influencing factors valuable to investigate malaria transmission dynamics in Cameroon.

methodsA total of 350 P. falciparum clinical isolates were characterized by genotyping block 2 of msp-1, block 3 of msp-2, and region II of glurp gene using nested PCR and DNA sequencing between 2012 and 2013.

resultsA total of 5 different genotypes with fragment sizes ranging from 597 to 817 bp were recorded for GLURP. Overall, 16 MSP-1 genotypes, including K1, MAD20 and RO33 were identified, ranging from 153 to 335 bp. A peculiarity about this study is the RO33 monomorphic pattern revealed among the Pfmsp-1 allelic type. Again, this study identified 27 different Pfmsp-2 genotypes, ranging from 140 to 568 bp in size, including 15 belonging to the 3D7-type and 12 to the FC27 allelic families. The analysis of the MSP-1 and MSP-2 peptides indicates that the region of the alignment corresponding K1 polymorphism had the highest similarity in the MSP1and MSP2 clade followed by MAD20 with 93% to 100% homology. Therefore, population structure of P. falciparum isolates is identical to that of other areas in Africa, suggesting that vaccine developed with K1 and MAD20 of Pfmsp1 allelic variant could be protective for Africa children but these findings requires further genetic and immunological investigations. The multiplicity of infection (MOI) was significantly higher (P < 0.05) for Pfmsp-2 loci (3.82), as compare with Pfmsp-1 (2.51) and heterozygotes ranged from 0.55 for Pfmsp-1 to 0.96 for Pfmsp-2.

conclusionHigh genetic diversity and allelic frequencies in P. falciparum isolates indicate a persisting high level of transmission. This study advocate for an intensification of the malaria control strategies in Cameroon. Trial registration This study was approved by Cameroon National Ethics Committee. It is a randomized controlled trial retrospectively registered in NIH U.S. National Library of Medicine, ClinicalTrials.gov on the 28/11/2016 at https://clinicaltrials.gov/ct2/show/NCT02974348 with the registration number NCT02974348.

Indexed as

Genetic VariationAllelesAntigens, ProtozoanCameroonChildChild, PreschoolDNA, ProtozoanFemaleGenotypeHumansInfantInfant, NewbornMalaria, FalciparumMaleMerozoite Surface Protein 1Plasmodium falciparumAntigens, ProtozoanDNA, ProtozoanMerozoite Surface Protein 1merozoite surface protein 2, PlasmodiumProtozoan ProteinsGLURP proteinHeterozygoteInfection controlMSP-1MSP-2Plasmodium

Identifiers

PMID32188442
PMCPMC7081701
OpenAlexW3012753992

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.